Oscar Health (NYSE:OSCR – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare Oscar Health to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings.
Profitability
This table compares Oscar Health and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Oscar Health | 3.60% | 38.45% | 6.76% |
| Oscar Health Competitors | -8.01% | -140.31% | -1.38% |
Valuation and Earnings
This table compares Oscar Health and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Oscar Health | $15.32 billion | -$443.15 million | 21.96 |
| Oscar Health Competitors | $19.20 billion | $288.54 million | 12.92 |
Oscar Health’s competitors have higher revenue and earnings than Oscar Health. Oscar Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 22.6% of Oscar Health shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility & Risk
Oscar Health has a beta of 2.56, suggesting that its stock price is 156% more volatile than the S&P 500. Comparatively, Oscar Health’s competitors have a beta of 0.99, suggesting that their average stock price is 1% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Oscar Health and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Oscar Health | 1 | 7 | 4 | 1 | 2.38 |
| Oscar Health Competitors | 1859 | 7716 | 13322 | 815 | 2.55 |
Oscar Health presently has a consensus price target of $34.60, indicating a potential upside of 12.55%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.55%. Given Oscar Health’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Oscar Health has less favorable growth aspects than its competitors.
Summary
Oscar Health beats its competitors on 8 of the 13 factors compared.
Oscar Health Company Profile
Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
